Not a Member?
Email this page
Send the page ""
to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
Farydak (panobinostat) REMS
Goal of the Farydak (panobinostat) REMS Program
The goal of the FARYDAK REMS is to mitigate the risks of severe diarrhea and cardiac toxicities (severe and fatal cardiac ischemic events, severe arrhythmias, and ECG changes) associated with FARYDAK treatment• by informing healthcare providers about the risks of severe diarrhea and cardiac toxicities associated with FARYDAK
• Communication Plan